Exchange: NASDAQ·Updated 07:30 PM EDT
NVNO logo

NVNO enVVeno Medical Corporation

$8.59
$0.575
(7.03%)
Today
Closed $8.75
$0.16
(1.83%)
After Hours
Reported EarningsJul 31
Mkt Cap$5.68M
Vol36,538.00

About NVNO

enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
44

Bearish Sentiment

How do you feel about NVNO?

Icemanja
$NVNO Berman still trying to Con investors out of their kids college fund. After already losing their retirement funds! What a loser quit already
5
Icemanja
$NVNO #WTF #FACT #BS Lets start with this one for transparency. Who leaked the FDA Rejection letter the day before the PR was released. JTC or Management? FACT OR BS
1
Icemanja
$NVNO Ask yourself this , being at all time low and the second go around at the product. Why is there ZERO institutional interest, they have the resources to do DD well ahead of retail. They had the same issue the first time, only 2 or 3 institutional backers. There is a reason NO reputable institutional investor wants to touch Enveno. FDA approval doesnt mean increased value if no demand. #WTF FACT OR FICTION
CasualTradeer
$NVNO 52 weeks low right now with 600K float. Could go parabolic once volume hits it, worth to add a lotto.
DARKP00L
$NVNO Envveno medical's first-in-class envve system to be featured at the veins 2026 innovation summit as company advances toward u.s. pivotal trial

Advertisement|Remove ads.